CA
APYX icon

Cliff Asness’s Apyx Medical APYX Stock Holding History

Cliff Asness’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-21,904
Closed -$122K – 2177
2020
Q2 		$122K Sell
21,904
-2,129
-9% -$8.85K ﹤0.01% 2046
2020
Q1 		$86K Buy
24,033
+8,256
+52% +$55.4K ﹤0.01% 1981
2019
Q4 		$133K Sell
15,777
-6,472
-29% -$46.8K ﹤0.01% 2056
2019
Q3 		$151K Buy
+22,249
New +$158K ﹤0.01% 2049

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Cliff Asness's APYX Position: Q3 2020 in Review

Cliff Asness sold out of Apyx Medical (APYX) in Q3 2020, closing a stake of 21,904 shares — an estimated $122K sold.

Cliff Asness first reported a position in APYX in Q3 2019 and held it in 4 quarters. The position peaked at $151K in Q3 2019. 61 funds tracked by Wall St. Rank hold APYX as of Q3 2020.

  • Cliff Asness reported no remaining Apyx Medical position as of Q3 2020 after selling out during the quarter.
  • Cliff Asness sold 21,904 Apyx Medical shares in Q3 2020, an estimated $122K.
  • Cliff Asness first reported a position in Apyx Medical in Q3 2019 and held it in 4 quarters.
  • Cliff Asness's Apyx Medical position peaked at $151K in Q3 2019.
  • 61 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2020.

Based on AQR Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.